Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Amerant Bancorp Inc.AMTB · Entity 4887 | Director | June 07, 2023 | June 09, 2023 |
| Global Crossing Airlines Group Inc.JETMF · Entity 7307 | Director | February 03, 2022 | March 21, 2022 |
| Industrial Human Capital, Inc.AXH · Entity 126646 | Director | October 19, 2021 | November 02, 2021 |
| Relativity Acquisition CorpRACYU · Entity 116251 | Director | February 10, 2022 | February 10, 2022 |
| SMITHFIELD FOODS INCSFD · Entity 3600 | Director | June 02, 2026 | June 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Amerant Bancorp Inc.
Report date June 07, 2023 · Filed June 09, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,225 |
Reported balance
After 2023-06-09 transaction · row 1
1 source rowRow 1 · 2023-06-09 · Exercise / conversion · Acquired 1,725 · Balance 2,225 F1: Each restricted stock unit is the economic equivalent of one share of Class A Common Stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 4,617 |
Reported balance
After 2023-06-07 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2023-06-07 · Grant · Acquired 2,892 · Balance 4,617 F1: Each restricted stock unit is the economic equivalent of one share of Class A Common Stock. F2: On June 7, 2023, the reporting person was granted 2,892 restricted stock units. Such restricted stock unit award will vest on the first anniversary of the date of the grant, provided that the reporting person remains in continuous service of the Company as a Director through the annual meeting of the shareholders of the Company to be held in 2024. Each restricted stock unit represents a right to receive one share of Class A Common Stock upon vesting. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 2,892 |
Reported balance
After 2023-06-09 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2023-06-09 · Exercise / conversion · Disposed 1,725 · Balance 2,892 F1: Each restricted stock unit is the economic equivalent of one share of Class A Common Stock. F3: On June 9, 2022, the reporting person was granted 1,725 restricted stock units vesting on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit is the economic equivalent of one share of Class A Common Stock.
F2: On June 7, 2023, the reporting person was granted 2,892 restricted stock units. Such restricted stock unit award will vest on the first anniversary of the date of the grant, provided that the reporting person remains in continuous service of the Company as a Director through the annual meeting of the shareholders of the Company to be held in 2024. Each restricted stock unit represents a right to receive one share of Class A Common Stock upon vesting.
F3: On June 9, 2022, the reporting person was granted 1,725 restricted stock units vesting on the first anniversary of the grant date.
Global Crossing Airlines Group Inc.
Report date February 03, 2022 · Filed March 21, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.58 · Expires 2025-09-23 | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2022-02-03 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed |
Industrial Human Capital, Inc.
Report date October 19, 2021 · Filed November 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,000 |
Reported balance
Holding disclosure · report date 2021-10-19 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 5,000 |
Relativity Acquisition Corp
Report date February 10, 2022 · Filed February 10, 2022
This filing explicitly reported no securities owned.
SMITHFIELD FOODS INC
Report date June 02, 2026 · Filed June 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 15,915 |
Reported balance
After 2026-06-02 transaction · row 1
1 source rowRow 1 · 2026-06-02 · Grant · Acquired 6,915 · Balance 15,915 F1: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the day of the annual meeting of the Company's shareholders to occur in 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the day of the annual meeting of the Company's shareholders to occur in 2027.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ALERE INC.
Report date October 03, 2017 · Filed October 03, 2017
Section 16 reporting ended · disclosed 2017-10-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-10-03 transaction · row 1
1 source rowRow 1 · 2017-10-03 · Disposition to issuer · Disposed 26,651 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration"). |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $29.55 | Direct | 0 |
Reported balance
After 2017-10-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-10-03 · Disposition to issuer · Disposed 41,336 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.73 | Direct | 0 |
Reported balance
After 2017-10-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-10-03 · Disposition to issuer · Disposed 56,274 · Balance 0 F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration").
F2: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option.
Aramark
Report date October 04, 2019 · Filed October 08, 2019
Section 16 reporting ended · disclosed 2019-10-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,780.7103 |
Reported balance
After 2019-10-04 transaction · row 1
1 source rowRow 1 · 2019-10-04 · Grant · Acquired 585 · Balance 28,780.7103 F1: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 3, 2026 20:49 UTC | SMITHFIELD FOODS INC SFD · Entity 3600 | GrantCommon Stock | 6,915 | $0.00 | $0.00 |
DisclosureSEC source: 0001222423-26-000001 · wk-form4_1780519764.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,915 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the day of the annual meeting of the Company's shareholders to occur in 2027. Read SEC document |
| January 29, 2025 Filed Jan 30, 2025 22:04 UTC | SMITHFIELD FOODS INC SFD · Entity 3600 | GrantCommon Stock, no par value ("Common Stock") | 9,000 | $20.00 | $180,000.00 |
DisclosureSEC source: 0001628280-25-003199 · wk-form4_1738274666.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 F1 · shares: Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs will vest on the day of the annual meeting of the Company's shareholders to occur in 2026. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 16:52 UTC | Amerant Bancorp Inc. AMTB · Entity 4887 | Exercise / conversionRestricted Stock Units · Derivative | 1,725 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001222423-23-000002 · wk-form4_1686329523.xml · derivative · entry 3 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,892 Underlying: Class A Common Stock · 1,725 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Class A Common Stock. F3 · derivative.exercise_date: On June 9, 2022, the reporting person was granted 1,725 restricted stock units vesting on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 9, 2022, the reporting person was granted 1,725 restricted stock units vesting on the first anniversary of the grant date. Read SEC document |
| June 09, 2023 Filed Jun 9, 2023 16:52 UTC | Amerant Bancorp Inc. AMTB · Entity 4887 | Exercise / conversionClass A Common Stock | 1,725 | $0.00 | $0.00 |
DisclosureSEC source: 0001222423-23-000002 · wk-form4_1686329523.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit is the economic equivalent of one share of Class A Common Stock. Read SEC document |
| June 07, 2023 Filed Jun 9, 2023 16:52 UTC | Amerant Bancorp Inc. AMTB · Entity 4887 | GrantRestricted Stock Units · Derivative | 2,892 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001222423-23-000002 · wk-form4_1686329523.xml · derivative · entry 2 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,617 Underlying: Class A Common Stock · 2,892 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Class A Common Stock. F2 · derivative.exercise_date: On June 7, 2023, the reporting person was granted 2,892 restricted stock units. Such restricted stock unit award will vest on the first anniversary of the date of the grant, provided that the reporting person remains in continuous service of the Company as a Director through the annual meeting of the shareholders of the Company to be held in 2024. Each restricted stock unit represents a right to receive one share of Class A Common Stock upon vesting. F2 · derivative.expiration_date: On June 7, 2023, the reporting person was granted 2,892 restricted stock units. Such restricted stock unit award will vest on the first anniversary of the date of the grant, provided that the reporting person remains in continuous service of the Company as a Director through the annual meeting of the shareholders of the Company to be held in 2024. Each restricted stock unit represents a right to receive one share of Class A Common Stock upon vesting. Read SEC document |
| June 09, 2022 Filed Jun 10, 2022 20:55 UTC | Amerant Bancorp Inc. AMTB · Entity 4887 | GrantRestricted Stock Units · Derivative | 1,725 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001222423-22-000006 · wf-form4_165489449222701.xml · derivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,725 Underlying: Class A Common Stock · 1,725 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit is the economic equivalent of one share of Class A Common Stock. F2 · derivative.exercise_date: On June 9, 2022 the reporting person was awarded 1,725 restricted stock units. Each restricted stock unit represents the right to receive, following vesting, one share of Class A common stock. The 1,725 restricted stock units will vest on the last business day preceding the Company's 2023 annual meeting, provided that the reporting person remains in the continuous service of the Company through such date. F2 · derivative.expiration_date: On June 9, 2022 the reporting person was awarded 1,725 restricted stock units. Each restricted stock unit represents the right to receive, following vesting, one share of Class A common stock. The 1,725 restricted stock units will vest on the last business day preceding the Company's 2023 annual meeting, provided that the reporting person remains in the continuous service of the Company through such date. Read SEC document |
| May 02, 2022 Filed May 3, 2022 21:18 UTC | Amerant Bancorp Inc. AMTB · Entity 4887 | PurchaseClass A Common Stock | 500 | $26.28 | $13,140.50 |
DisclosureSEC source: 0001222423-22-000004 · wf-form4_165161268645526.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Read SEC document |
| October 04, 2019 Filed Oct 8, 2019 17:39 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 585 | $42.71 | $24,985.35 |
DisclosureSEC source: 0001584509-19-000191 · wf-form4_157057076670699.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,780.7103 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| August 29, 2019 Filed Sep 3, 2019 21:33 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 76.093 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000184 · wf-form4_156756078276383.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,195.7103 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| July 05, 2019 Filed Jul 8, 2019 16:16 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 688 | $36.31 | $24,981.28 |
DisclosureSEC source: 0001584509-19-000146 · wf-form4_156261696158487.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,119.6173 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| May 30, 2019 Filed Jun 3, 2019 18:24 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 86.215 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000137 · wf-form4_155960062764437.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,431.6173 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| April 05, 2019 Filed Apr 9, 2019 21:06 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 818 | $30.55 | $24,989.90 |
DisclosureSEC source: 0001584509-19-000102 · wf-form4_155485835436906.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,345.4023 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 16:46 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 95.955 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000074 · wf-form4_155173596378366.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,527.4023 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| January 30, 2019 Filed Feb 1, 2019 16:38 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 4,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-19-000024 · wf-form4_154905711471288.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,431.4473 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 16:46 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 856 | $29.19 | $24,986.64 |
DisclosureSEC source: 0001584509-19-000005 · wf-form4_154698395523519.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,523.4473 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 06, 2018 Filed Dec 10, 2018 17:00 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 60.209 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000255 · wf-form4_154447919842183.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,667.4473 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| October 08, 2018 Filed Oct 10, 2018 20:04 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 605 | $41.29 | $24,980.45 |
DisclosureSEC source: 0001584509-18-000194 · wf-form4_153921623077644.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,607.2383 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| August 30, 2018 Filed Sep 4, 2018 19:03 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 51.158 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000182 · wf-form4_153610217549347.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,002.2383 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| July 09, 2018 Filed Jul 11, 2018 18:30 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 654 | $38.21 | $24,989.34 |
DisclosureSEC source: 0001584509-18-000143 · wf-form4_153134818379014.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,951.0803 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 18:18 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 52.053 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000129 · wf-form4_152815066263854.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,297.0803 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| April 06, 2018 Filed Apr 10, 2018 18:36 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 648 | $38.55 | $24,980.40 |
DisclosureSEC source: 0001584509-18-000084 · wf-form4_152339978734693.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,245.0273 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 16:55 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 47.645 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000074 · wf-form4_152028694303834.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,597.0273 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| January 31, 2018 Filed Feb 2, 2018 16:16 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 3,493 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-18-000036 · wf-form4_151760615188539.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,549.3823 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| January 05, 2018 Filed Jan 9, 2018 19:01 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 585 | $42.72 | $24,991.20 |
DisclosureSEC source: 0001584509-18-000010 · wf-form4_151554248596536.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,056.3823 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 07, 2017 Filed Dec 11, 2017 18:10 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 35.6314 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000276 · wf-form4_151303378711625.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,471.3823 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| October 07, 2017 Filed Oct 10, 2017 17:05 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 603 | $41.42 | $24,976.26 |
DisclosureSEC source: 0001584509-17-000210 · wf-form4_150766951682344.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,435.7509 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| October 03, 2017 Filed Oct 3, 2017 17:40 UTC | ALERE INC. ALR · Entity 172772 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 56,274 | Not disclosed Strike: $33.73 | Not disclosed |
DisclosureSEC source: 0000950142-17-001795 · es1701019_4-quelch.xml · derivative · entry 3 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 56,274 shares Expires not disclosed F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. Read SEC document |
| October 03, 2017 Filed Oct 3, 2017 17:40 UTC | ALERE INC. ALR · Entity 172772 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 41,336 | Not disclosed Strike: $29.55 | Not disclosed |
DisclosureSEC source: 0000950142-17-001795 · es1701019_4-quelch.xml · derivative · entry 2 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,336 shares Expires not disclosed F2 · price: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. F2 · derivative.exercise_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. F2 · derivative.expiration_date: Pursuant to the Merger Agreement, at the Effective Time, each outstanding Employee Stock Option, whether vested or unvested, was canceled and converted into the right to receive a lump-sum cash payment equal to the product of (i) the number of shares of Common Stock for which such Employee Stock Option has not been exercised and (ii) the excess, if any, of the Merger Consideration over the exercise price per share of such Employee Stock Option. Read SEC document |
| October 03, 2017 Filed Oct 3, 2017 17:40 UTC | ALERE INC. ALR · Entity 172772 | Disposition to issuerCommon Stock | 26,651 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950142-17-001795 · es1701019_4-quelch.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to that certain Agreement and Plan of Merger, dated as of January 30, 2016, as amended on April 13, 2017 (the "Merger Agreement"), between Alere Inc. (the "Company") and Abbott Laboratories, at the Effective Time (as defined in the Merger Agreement) (the "Effective Time"), each of these shares of the Company's common stock (the "Common Stock") was converted into the right to receive $51.00 (the "Merger Consideration"). Read SEC document |
| September 05, 2017 Filed Sep 7, 2017 18:16 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 35.2553 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000197 · wf-form4_150482256150102.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,832.7509 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| July 07, 2017 Filed Jul 11, 2017 17:19 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 621 | $40.24 | $24,989.04 |
DisclosureSEC source: 0001584509-17-000158 · wf-form4_149980793019506.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,797.4956 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:07 UTC | ALERE INC. ALR · Entity 172772 | Exercise / conversionRestricted Stock Units · Derivative | 5,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-010139 · edgar.xml · derivative · entry 2 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Alere common stock. F2 · derivative.exercise_date: The restricted stock units vested in full on June 30, 2017. F2 · derivative.expiration_date: The restricted stock units vested in full on June 30, 2017. Read SEC document |
| June 30, 2017 Filed Jul 5, 2017 21:07 UTC | ALERE INC. ALR · Entity 172772 | Exercise / conversionCommon Stock | 5,530 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001179110-17-010139 · edgar.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,651 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of Alere common stock. Read SEC document |
| June 06, 2017 Filed Jun 8, 2017 17:21 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 34.6812 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000134 · wf-form4_149695687930626.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,176.4956 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| April 07, 2017 Filed Apr 11, 2017 17:20 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 685 | $36.46 | $24,975.10 |
DisclosureSEC source: 0001584509-17-000093 · wf-form4_149194563550812.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,141.8144 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:46 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 35.8465 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000076 · wf-form4_148857756394001.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,456.8144 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:37 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 35.8465 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000075 · wf-form4_148857706113207.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,456.8144 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 17:17 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 4,825 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-17-000026 · wf-form4_148616024274621.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,420.9679 F1 · price: Represents a grant of deferred stock units, which will vest on the day prior to the first annual stockholders' meeting of the Company occurring after the grant date, subject to continued service, and, if vested, will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| January 06, 2017 Filed Jan 10, 2017 17:40 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 715 | $34.92 | $24,967.80 |
DisclosureSEC source: 0001584509-17-000010 · wf-form4_148408801770402.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,595.9679 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| December 08, 2016 Filed Dec 12, 2016 17:26 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 19.5821 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-16-000545 · wf-form4_148158156904228.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,880.9679 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
| November 15, 2016 Filed Nov 17, 2016 17:59 UTC | ALERE INC. ALR · Entity 172772 | GrantRestricted Stock Units · Derivative | 5,530 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-16-031803 · edgar.xml · derivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,530 Underlying: Common Stock · 5,530 shares Expires not disclosed F3 · security: All prior equity awards granted to the Reporting Person had vested in full on or prior to June 30, 2016. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Alere common stock. F2 · derivative.exercise_date: The restricted stock units will vest in full on June 30, 2017. F2 · derivative.expiration_date: The restricted stock units will vest in full on June 30, 2017. Read SEC document |
| October 07, 2016 Filed Oct 11, 2016 17:17 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 679 | $36.81 | $24,993.99 |
DisclosureSEC source: 0001584509-16-000485 · wf-form4_147622065859629.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,861.3858 F1 · price: Represents a grant of fully vested deferred stock units into which the director has elected to defer all of his cash retainer, which will be settled in shares of common stock on the first day of the seventh month after the date of the director's departure from the board. Read SEC document |
| September 06, 2016 Filed Sep 8, 2016 17:22 UTC | Aramark ARMK · Entity 3359 | GrantCommon Stock | 15.4013 | $0.00 | $0.00 |
DisclosureSEC source: 0001584509-16-000470 · wf-form4_147336970888309.xml · nonDerivative · entry 1 QUELCH JOHN · CIK 0001222423 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,182.3858 F1 · shares: Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on deferred stock units held by the reporting person. These dividend equivalent rights vest on the same schedules as the underlying awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.